The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction

International Journal of Cardiovascular Imaging

Volumn 29, Issue 7, 2013, Pages 1645-1653

  Uebleis, Christopher ^a   Hellweger, Stefan ^a   Laubender, Rüdiger Paul ^a   Becker, Alexander ^a   Sohn, Hae Young ^a   Lehner, Sebastian ^a   Haug, Alexander ^a   Bartenstein, Peter ^a   Cumming, Paul ^a   Van Kriekinge, Serge D ^b   Slomka, Piotr J ^b   Hacker, Marcus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hibernation; Metabolism; Prognosis; Revascularization; Survival

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE;

ADULT; ARTICLE; BYPASS SURGERY; CORRELATION ANALYSIS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; ISCHEMIC CARDIOMYOPATHY; KAPLAN MEIER METHOD; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOMYOPATHIES; CORONARY ARTERY BYPASS; FLUORODEOXYGLUCOSE F18; HUMANS; KAPLAN-MEIER ESTIMATE; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL STUNNING; MYOCARDIUM; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84893682284     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-013-0254-2     Document Type: Article

References (26)

1. Bonow RO, Maurer G, Lee KL et al (2011) Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 364:1617-1625
2. Camici PG, Prasad SK, Rimoldi OE (2008) Stunning, hibernation, and assessment of myocardial viability. Circulation 117: 103-114
3. Underwood SR, Bax JJ, vom Dahl J et al (2004) Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 25:815-836
4. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH (2007) Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32:375-410
5. Tarakji KG, Brunken R, McCarthy PM et al (2006) Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 113:230-237
6. Zhang X, Liu XJ, Wu Q et al (2001) Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99 m)Tc-MIBI SPECT and (18)F-FDG PET. J Nucl Med 42:1166-1173
7. Beanlands RS, Nichol G, Huszti E et al (2007) F-18-fluorodeoxyglucose positron emission tomography imaging-Assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 50:2002-2012
8. Bax JJ, Visser FC, Poldermans D et al (2001) Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 42:79-86
9. Kuhl HP, Lipke CS, Krombach GA et al (2006) Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomographysingle photon emission computed tomography imaging protocol. Eur Heart J 27:846-853
10. Pace L, Perrone-Filardi P, Storto G et al (2000) Prediction of improvement in global left ventricular function in patients with chronic coronary artery disease and impaired left ventricular function: rest thallium-201 SPET versus low-dose dobutamine echocardiography. Eur J Nucl Med 27:1740-1746
11. Slart RH, Bax JJ, van Veldhuisen DJ et al (2006) Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13 N-Ammonia/18F-FDG PET. Eur J Nucl Med Mol Imag 33:716-723
12. Bax JJ, Visser FC, van Lingen A, Cornel JH, Fioretti PM, van der Wall EE (1997) Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability. Int J Card Imag 13:145-155 Discussion 157-160
13. Slomka PJ, Nishina H, Berman DS et al (2004) Automatic quantification of myocardial perfusion stress-rest change: a new measure of ischemia. J Nucl Med 45:183-191
14. Beanlands RS, Ruddy TD, de Kemp RA (2002) Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 40:1735-1743
15. Slomka PJ, Nishina H, Berman DS et al (2005) Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol 12:66-77
16. Gottlieb SS (1997) Dead is dead-Artificial definitions are no substitute. Lancet 349:662-663
17. Lauer MS, Blackstone EH, Young JB, Topol EJ (1999) Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 34:618-620
18. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933-989
19. Velazquez EJ, Lee KL, Deja MA et al (2011) Coronary-Artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364:1607-1616
20. D'Egidio G, Nichol G, Williams KA et al (2009) Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imag 2:1060-1068
21. Desideri A, Cortigiani L, Christen AI et al (2005) The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 46:1264-1269
22. Di Carli MF, Davidson M, Little R et al (1994) Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73:527-533
23. Lee KS, Marwick TH, Cook SA et al (1994) Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 90:2687-2694
24. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900-7. Epub 2003 May 27
25. Canty JM Jr, Suzuki G, Banas MD, Verheyen F, Borgers M, Fallavollita JA (2004) Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death. Circ Res 94:1142-1149
26. Nkoulou R, Pazhenkottil AP, Buechel RR et al (2011) Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/18F-FDG PET. Int J Cardiovasc Imag 27:913-921